GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID | Title | Descriptor ▲ |
---|---|---|---|
2IWG | P19474 | COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC | IG GAMMA-1 CHAIN C, 52 KDA RO PROTEIN |
3ZO0 | P01863 | Mouse IgG2a in complex with mouse TRIM21 PRYSPRY | IG GAMMA-2A CHAIN C REGION, A ALLELE, E3 UBIQUITIN-PROTEIN LIGASE TRIM21 (E.C.6.3.2.-) |
3ZO0 | Q62191 | Mouse IgG2a in complex with mouse TRIM21 PRYSPRY | IG GAMMA-2A CHAIN C REGION, A ALLELE, E3 UBIQUITIN-PROTEIN LIGASE TRIM21 (E.C.6.3.2.-) |
2FBJ | P01810 | REFINED CRYSTAL STRUCTURE OF THE GALACTAN-BINDING IMMUNOGLOBULIN FAB J539 AT 1.95-ANGSTROMS RESOLUTION | IGA FAB FRAGMENT (J539) (GALACTAN-BINDING) |
2FBJ | 437099 | REFINED CRYSTAL STRUCTURE OF THE GALACTAN-BINDING IMMUNOGLOBULIN FAB J539 AT 1.95-ANGSTROMS RESOLUTION | IGA FAB FRAGMENT (J539) (GALACTAN-BINDING) |
1CLY | 1CLY | IGG FAB (HUMAN IGG1, KAPPA) CHIMERIC FRAGMENT (CBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER | IGG FAB (HUMAN IGG1, KAPPA), METHYL NONANOATE (ESTER) |
1CLZ | P22436 | IGG FAB (IGG3, KAPPA) FRAGMENT (MBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER | IGG FAB (IGG3, KAPPA), METHYL NONANOATE (ESTER) |
1CLZ | PC4203 | IGG FAB (IGG3, KAPPA) FRAGMENT (MBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER | IGG FAB (IGG3, KAPPA), METHYL NONANOATE (ESTER) |
1IGF | S38864 | CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS | IGG1 FAB' FRAGMENT (B13I2) |
1IGF | PC4203 | CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS | IGG1 FAB' FRAGMENT (B13I2) |
2IGF | S38864 | CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS | IGG1 FAB' FRAGMENT (B13I2) COMPLEX WITH PEPTIDE (RESIDUES 69-87 OF MYOHEMERYTHRIN) |
2IGF | PC4203 | CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS | IGG1 FAB' FRAGMENT (B13I2) COMPLEX WITH PEPTIDE (RESIDUES 69-87 OF MYOHEMERYTHRIN) |
2IGF | P02247 | CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS | IGG1 FAB' FRAGMENT (B13I2) COMPLEX WITH PEPTIDE (RESIDUES 69-87 OF MYOHEMERYTHRIN) |
1MFB | 208365 | HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA | IGG1-LAMBDA SE155-4 FAB |
1MFB | 387376 | HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA | IGG1-LAMBDA SE155-4 FAB |
1MFC | 208365 | HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA | IGG1-LAMBDA SE155-4 FAB |
1MFC | 387376 | HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA | IGG1-LAMBDA SE155-4 FAB |
1MFD | 208365 | THE SOLUTION STRUCTURE OF A TRISACCHARIDE-ANTIBODY COMPLEX: COMPARISON OF NMR MEASUREMENTS WITH A CRYSTAL STRUCTURE | IGG1-LAMBDA SE155-4 FAB |
1MFD | 387376 | THE SOLUTION STRUCTURE OF A TRISACCHARIDE-ANTIBODY COMPLEX: COMPARISON OF NMR MEASUREMENTS WITH A CRYSTAL STRUCTURE | IGG1-LAMBDA SE155-4 FAB |
1HZH | P0DOX5 | CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN | IMMUNOGLOBULIN (HEAVY CHAIN, LIGHT CHAIN) |
1HZH | 1HZH | CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN | IMMUNOGLOBULIN (HEAVY CHAIN, LIGHT CHAIN) |
1HZH | P0DOX5 | CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN | IMMUNOGLOBULIN (HEAVY CHAIN, LIGHT CHAIN) |
1HZH | 1HZH | CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN | IMMUNOGLOBULIN (HEAVY CHAIN, LIGHT CHAIN) |
1HZH | Q8TCD0 | CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN | IMMUNOGLOBULIN (HEAVY CHAIN, LIGHT CHAIN) |
1HZH | Q8TCD0 | CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN | IMMUNOGLOBULIN (HEAVY CHAIN, LIGHT CHAIN) |
1FC2 | P02976 | Crystallographic Refinement and Atomic Models of a Human FC Fragment and its Complex with Fragment B of Protein A from Staphylococcus Aureus at 2.9-and 2.8-Angstroms Resolution | IMMUNOGLOBULIN FC AND FRAGMENT B OF PROTEIN A COMPLEX |
1FC2 | Y14737 | Crystallographic Refinement and Atomic Models of a Human FC Fragment and its Complex with Fragment B of Protein A from Staphylococcus Aureus at 2.9-and 2.8-Angstroms Resolution | IMMUNOGLOBULIN FC AND FRAGMENT B OF PROTEIN A COMPLEX |
1MCO | 243866 | THREE-DIMENSIONAL STRUCTURE OF A HUMAN IMMUNOGLOBULIN WITH A HINGE DELETION | IMMUNOGLOBULIN G1 (IGG1) (MCG) WITH A HINGE DELETION |
1MCO | S14675 | THREE-DIMENSIONAL STRUCTURE OF A HUMAN IMMUNOGLOBULIN WITH A HINGE DELETION | IMMUNOGLOBULIN G1 (IGG1) (MCG) WITH A HINGE DELETION |
1IVG | P06820 | STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE | INFLUENZA A SUBTYPE N2 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) |
1INW | P06820 | A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES | INFLUENZA A SUBTYPE N2 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH APANA INHIBITOR (4-ACETAMIDO-2,4-DIDEOXY-D-GLYCERO-BETA-D-GALACTO-1-OCTOPYRANOSYL) PHOSPHONIC ACID |
1IVD | P06820 | STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE | INFLUENZA A SUBTYPE N2 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH AROMATIC BANA105 INHIBITOR (4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID) |
1IVC | P06820 | STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE | INFLUENZA A SUBTYPE N2 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH AROMATIC BANA106 INHIBITOR (4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID) |
1IVE | P06820 | STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE | INFLUENZA A SUBTYPE N2 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH AROMATIC BANA108 INHIBITOR (4-(ACETYLAMINO)-3-AMINOBENZOIC ACID) |
1IVF | P06820 | STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE | INFLUENZA A SUBTYPE N2 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH DANA INHIBITOR (2-DEOXY-2,3-DIDEHYDRO-D-N-ACETYLNEURAMINIC ACID) |
1INX | P06820 | A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES | INFLUENZA A SUBTYPE N2 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH EPANA INHIBITOR (4-ACETAMIDO-2,4-DIDEOXY-D-GLYCERO-ALPHA-D-GALACTO-1-OCTOPYRANOSYL) PHOSPHONIC ACID |
1INH | P06820 | INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA111 INHIBITOR | INFLUENZA A SUBTYPE N2 NEURAMINIDASE, 4-(ACETYLAMINO)-3-[(AMINOACETYL)AMINO]BENZOIC ACID |
1ING | P06820 | INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA109 INHIBITOR | INFLUENZA A SUBTYPE N2 NEURAMINIDASE, 4-(ACETYLAMINO)-3-[(HYDROXYACETYL)AMINO]BENZOIC ACID |
1INY | P03472 | A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES | INFLUENZA A SUBTYPE N9 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH EPANA INHIBITOR (4-ACETAMIDO-2,4-DIDEOXY-D-GLYCERO-ALPHA-D-GALACTO-1-OCTOPYRANOSYL) PHOSPHONIC ACID |
1INV | P03474 | A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES | INFLUENZA B/LEE/40 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH EPANA INHIBITOR (4-ACETAMIDO-2,4-DIDEOXY-D-GLYCERO-ALPHA-D-GALACTO-1-OCTOPYRANOSYL) PHOSPHONIC ACID |
1IVB | P03474 | STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE | INFLUENZA VIRUS B/LEE/40 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH BANA105 INHIBITOR (4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID) |
1INF | P03474 | INFLUENZA VIRUS B/LEE/40 NEURAMINIDASE COMPLEXED WITH BANA113 INHIBITOR | INFLUENZA VIRUS B/LEE/40 NEURAMINIDASE, 4-(ACETYLAMINO)-3-GUANIDINOBENZOIC ACID |
1EO8 | P03437 | INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY | INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY |
1EO8 | 7159939 | INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY | INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY |
1EO8 | 7159941 | INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY | INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY |
1LRT | P50097 | CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRITRICHOMONAS FOETUS INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE: STRUCTURAL CHARACTERIZATION OF NAD+ SITE IN MICROBIAL ENZYME | INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE (E.C.1.1.1.205) |
4CAK | P08514 | Three-dimensional reconstruction of intact human integrin alphaIIbbeta3 in a phospholipid bilayer nanodisc | INTEGRIN ALPHA-IIB, INTEGRIN BETA-3 |
4CAK | P05106 | Three-dimensional reconstruction of intact human integrin alphaIIbbeta3 in a phospholipid bilayer nanodisc | INTEGRIN ALPHA-IIB, INTEGRIN BETA-3 |
2VDO | P08514 | Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide, HHLGGAKQAGDV | INTEGRIN ALPHA-IIB, INTEGRIN BETA-3, FIBRINOGEN, GAMMA POLYPEPTIDE, MONOCLONAL ANTIBODY 10E5 HEAVY CHAIN, MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN |
2VDO | P05106 | Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide, HHLGGAKQAGDV | INTEGRIN ALPHA-IIB, INTEGRIN BETA-3, FIBRINOGEN, GAMMA POLYPEPTIDE, MONOCLONAL ANTIBODY 10E5 HEAVY CHAIN, MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024